The Global Metabolomics Market is expected to reach $3.83 billion by 2024 at growth
Access Sample Report: www.reportsnreports.com/contacts/r…aspx?name=214354
The metabolomics market has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies.
Metabolomics Companies Profiled In Report: Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc.
(U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.) Bio-Rad Laboratories (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc.
(Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.).
In this report, the global metabolomic market is segmented by product and service, application, indication, and region. Based on product and service, this market is further segmented into two major segments—metabolomics instruments and metabolomics bioinformatics tools & services.
Based on metabolomics instruments, the market is further segmented into detection tools and separation tools. The separation tools segment commanded the largest share in the global metabolomics instruments market in 2015.
The large share of this segment can be attributed to the ease of separation, characterization of metabolites, and quantitation of chemical compounds achieved by separation tools such as UPLC.
Based on application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. In 2015, the biomarker discovery segment accounted for the largest share of the global metabolomics market.
The personalized medicine segment is expected to register the highest CAGR during the forecast period due to collaborations between pharmaceutical companies and biotechnology firms for biomarker discovery and validation.
In 2015, North America commanded the largest share of the metabolomics market, followed by Europe. The U.S. is the prime market for metabolomics due to the rising acceptance of personalized medicines and growing focus of stakeholders on research projects involving metabolites, amino acid composition, and associated biomolecules in the country.
The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers on this region.
Inquire about report @ www.reportsnreports.com/contacts/i…aspx?name=214354
Metabolomics Market Overview –
Detailed insights on all the sub markets, based on metabolomics instruments (Gas Chromatography, Capillary Electrophoresis, High-performance Liquid Chromatography, Ultra-performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, and Surface-based Mass Analysis), this can help market players to identify high growth segments in the metabolomics market.
The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.
Key insights and market sizing for the different end users of the metabolomics market namely, hospitals, laboratories, academic institutes, biotechnology firms, clinical research laboratories, and other end users.
Country-wise market size and forecast for all the sub segments. Thus, not only the high growth product & service, technology, application, and indication areas; the market size numbers provided in the report will also enable players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.
Access report at: www.reportsnreports.com/purchase.aspx?name=214354